Buy Drugs Online:
Drugs Information:
Drugs List

1. Name Of The Medicinal Product

Quetiapine 25 mg Film-coated Tablets

2. Qualitative And Quantitative Composition

Each film-coated tablet contains 25 mg (as quetiapine hemifumarate).

Excipient (s):

Each 25 mg film-coated tablet contains 13.300 mg lactose monohydrate.

For a full list of excipients, see section 6.1

3. Pharmaceutical Form

Film-coated tablet

25mg tablets are pink coloured, round, biconvex, film-coated tablet, plain on both sides.

4. Clinical Particulars

4.1 Therapeutic Indications

Quetiapine tablet is indicated for the treatment of:

• Schizophrenia.

• Bipolar disorder, including:

 

• moderate to severe manic episodes in bipolar disorder

 

• major depressive episodes in bipolar disorder

 

• prevention of recurrence in patients whose manic or depressive episode has responded to quetiapine treatment.

4.2 Posology And Method Of Administration

Quetiapine tablets can be administered, with or without food.

Adults

For the treatment of schizophrenia: Quetiapine tablets sho

1. Name Of The Medicinal Product

Quinapril/Hydrochlorothiazide 20/25 mg film-coated tablets

2. Qualitative And Quantitative Composition

20 /25 mg:

Each film-coated tablet contains 20 mg of quinapril equivalent to 21.66 mg of quinapril hydrochloride and 25 mg hydrochlorothiazide.

Excipient: Each film-coated tablet contains 36.90 mg of lactose (as lactose monohydrate).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Film-coated tablet.

20mg/25mg:

Pink coloured, round shaped, biconvex, film-coated tablets debossed with 'D' on one side and '20' on other side.

4. Clinical Particulars

4.1 Therapeutic Indications

Quinapril/Hydrochlorothiazide is indicated as substitution therapy only in adult patients with essential hypertension already adequately controlled with quinapril and hydrochlorothiazide given concurrently.

4.2 Posology And Method Of Administration

Posology

Patients receiving quinapril and hydrochlorothiazide from separate tablets may be switched to a combination tablets of Quinapril/Hydrochlorothiazide containing the same component doses.

Adults:

The recommended dose of Quinapril/Hydrochlorothiazide is one tablet per day.

Renal impairment

Due to hydrochlorothiazide component, Quinapril/Hydrochlorothiazide is contraindicated in patients with severe renal impairment (creatinine clearance < 30 ml/min) (see sections 4.3, 4.4 and 5.2).

Elderly patients (>65 years old)

The dose should be kept as low as possibl

Quinine Sulphate 300mg tablets

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you.
    Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

Index

1 What Quinine sulphate tablets are and what they are used for
2 Before you take
3 How to take
4 Possible side effects
5 How to store
6 Further information

What Quinine sulphate tablets are and what they are used for

Quinine sulphate belongs to a group of medicines called anti-protozoal agents and they are used to treat:

  • malaria
  • and prevent night cramps in adults and the elderly when sleep is regularly disrupted

Before you take

Do not take Quinine sulphate tablets and tell your doctor if you have:

  • an allergy (hypersensitivity) to quinine (including that in tonic waters or other beverages), quinoline or any of the other ingredients (see section 6)
  • blood in your urine
  • ringing in your ears
  • suffer from muscle weakness (myasthenia gravis)
  • problems with your eyes or difficulty seeing

Check with your doctor or pharmacist before taking Quinine sulphate tablet

1. Name Of The Medicinal Product

Qutenza

2. Qualitative And Quantitative Composition

Each 280 cm2 cutaneous patch contains a total of 179 mg of capsaicin or 640 micrograms of capsaicin per cm2 of patch (8 % w/w).

Excipient

Each 50 g tube of cleansing gel for Qutenza contains 0.2 mg/g butylhydroxyanisole (E320).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Cutaneous patch.

Each patch is 14 cm x 20 cm (280 cm2) and consists of an adhesive side containing the active substance and an outer surface backing layer. The adhesive side is covered with a removable, clear, unprinted, diagonally cut, release liner. The outer surface of the backing layer is imprinted with 'capsaicin 8%'.

4. Clinical Particulars

4.1 Therapeutic Indications

Qutenza is indicated for the treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain.

4.2 Posology And Method Of Administration

Qutenza should be applied to the most painful skin areas (using up to a maximum of 4 patches). The painful area should be determined by the physician and marked on the skin. Qutenza must be applied to intact, non-irritated, dry skin, and allowed to remain in place for 30 minutes for the feet (e.g. HIV-associated neuropathy) and 60 minutes for other locations (e.g. postherpetic neuralgia). Qutenza treatments may be repeated every 90 days, as warranted by the persistence or return of pain.

The Qutenza cutaneous patch should be applied by a physician or by a health care professional under the supervision of a physician.

Nitrile gloves sho

1. Name Of The Medicinal Product

Qvar 50 Autohaler 50 micrograms per actuation pressurised inhalation solution.

2. Qualitative And Quantitative Composition

Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.

(The dose delivered from the mouthpiece is an average 37.5 micrograms).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Pressurised inhalation, solution.

A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.

Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).

4. Clinical Particulars

4.1 Therapeutic Indications

Prophylactic management of mild, moderate or severe asthma.

4.2 Posology And Method Of Administration

Qvar is for inhalation use only.

Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.

NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.

ADULT STARTING AND MAINTENANCE DOSE:

It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.

To be effective, inhaled Qvar must be used on a regular basis even when patients are asymptomatic.

1. Name Of The Medicinal Product

QUINOCORT™ CREAM

2. Qualitative And Quantitative Composition

Potassium Hydroxyquinoline Sulphate BP

0.5%

Hydrocortisone BP

1.0%

3. Pharmaceutical Form

Quinocort Cream is a faintly yellow vanishing cream. It is intended for topical use only.

4. Clinical Particulars

4.1 Therapeutic Indications

The treatment of infected eczema, intertrigo and other steroid-responsive dermatoses where anti-infective cover is appropriate.

4.2 Posology And Method Of Administration

Route of administration: For topical use only.

Adults, children and the elderly

By gentle massage over all the affected area two to three times daily.

4.3 Contraindications

Patients with known sensitivity or intolerance to any of the ingredients.

4.4 Special Warnings And Precautions For Use

Contact with eyes and other mucosal surfaces should be avoided. Caution should be exercised when using this preparation in infants. Long term continuous topical therapy should be avoided in infants - adrenal suppression can occur even without occlusion.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

Not applicable.

4.6 Pregnancy And Lactation

In pregnant animals administration of corticosteroids can cause abnormalities of foetal development. The relevance o

1. Name Of The Medicinal Product

Quinine Bisulphate Tablets 300mg

2. Qualitative And Quantitative Composition

Quinine Bisulphate 300.00 mg BP

3. Pharmaceutical Form

Coated tablet

4. Clinical Particulars

4.1 Therapeutic Indications

The treatment of:- chloroquine-resistant malaria. Treatment and prevention of nocturnal leg cramps in adults and the elderly, when cramps cause regular disruption of sleep (see section 4.2 and Section 4.4)

4.2 Posology And Method Of Administration

Route of administration: Oral

For malaria:

Adults: in the treatment of chloroquine-resistant malaria - 600mg at 8 hourly intervals for 7 days.

Children: 10mg per kg bodyweight at 8 hourly intervals for 7 days

For the treatment and prevention of nocturnal leg cramps:

Adults (including elderly):

The recommended dose is 300mg at bedtime.

A reduction in frequency of leg cramps may take up to 4 weeks to become apparent. Patients should be monitored closely during the early stages of treatment for adverse effects. After an initial trial of 4 weeks, treatment should be stopped if there is no benefit. Treatment should be interrupted at approximately three monthly intervals to reassess the benefit of treatment.

Children: Not recommended

4.3 Contraindications

In patients with a history of hypersensitivity to quinine or any of the excipients in the tablet. In the presence of haemoglobinuria during malaria. Optic neuritis.

Tinnitus

Myasthenia gravis.

4.4 Special Warnings And Precautions For Use

Use with caution in pat

1. Name Of The Medicinal Product

Qlaira, film-coated tablets

2. Qualitative And Quantitative Composition

Each wallet (28 film-coated tablets) contains in the following order:

2 dark yellow tablets each containing 3 mg estradiol valerate

5 medium red tablets each containing 2 mg estradiol valerate and 2 mg dienogest

17 light yellow tablets each containing 2 mg estradiol valerate and 3 mg dienogest

2 dark red tablets each containing 1 mg estradiol valerate

2 white tablets do not contain active substances

Excipient: lactose (not more than 50 mg per tablet)

For a full list of excipients, see section 6.1. .

3. Pharmaceutical Form

Film-coated tablet (tablet).

Dark yellow film-coated tablet, round with biconvex faces, one side is embossed with the letters “DD” in a regular hexagon

Medium red film-coated tablet, round with biconvex faces, one side is embossed with the letters “DJ” in a regular hexagon

Light yellow film-coated tablet, round with biconvex faces, one side is embossed with the letters “DH” in a regular hexagon

Dark red film-coated tablet, round with biconvex faces, one side is embossed with the letters “DN” in a regular hexagon

White film-coated tablet, round with biconvex faces, one side is embossed with the letters “DT” in a regular hexagon

4. Clinical Particulars

4.1 Therapeutic Indications

Oral contraception.

4.2 Posology And Method Of Administration

How to take Qlaira

Tablets must be taken in the order directed on the package every day at about the same time with some liquid as needed. Tablet takin

1. Name Of The Medicinal Product

Quinoderm 5% / 0.5% w/w Cream

2. Qualitative And Quantitative Composition

Benzoyl Peroxide, hydrous

5.0% w/w

Potassium Hydroxyquinoline Sulphate

0.5% w/w

Excipients: Also includes cetostearyl alcohol, approx 0.825% w/w

For full list of excipients, see section 6.1

3. Pharmaceutical Form

Quinoderm Cream is a creamy white astringent vanishing cream. It is intended for topical use only.

4. Clinical Particulars

4.1 Therapeutic Indications

Acne vulgaris, acneform eruptions, folliculitis.

4.2 Posology And Method Of Administration

Route of administration

For topical use only.

Adults, children and the elderly

By gentle massage over all the affected area two or three times daily.

4.3 Contraindications

Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream.

4.4 Special Warnings And Precautions For Use

Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.

In a few isolated cases, overreaction to Quinoderm Cream may occur. To minimise this possibility,

1. Name Of The Medicinal Product

Quetiapine 300 mg Film-coated Tablets

2. Qualitative And Quantitative Composition

Each film-coated tablet contains 300 mg (as quetiapine hemifumarate).

Excipient (s):

Each 300 mg film-coated tablet contains 159.600 mg lactose monohydrate.

For a full list of excipients, see section 6.1

3. Pharmaceutical Form

Film-coated tablet

300mg tablets are white to off white, capsule shaped, biconvex, film-coated tablet, with '300' debossed on one side and plain on other side.

4. Clinical Particulars

4.1 Therapeutic Indications

Quetiapine tablet is indicated for the treatment of:

o Schizophrenia.

o Bipolar disorder, including:

        • moderate to severe manic episodes in bipolar disorder

        • major depressive episodes in bipolar disorder

        • prevention of recurrence in patients whose manic or depressive episode has responded to quetiapine treatment.

4.2 Posology And Method Of Administration

Quetiapine tablets can be administered, with or without food.

Adults

For the treatment of schizophrenia: Quetiapine tablets should be administered twice a daily. The total daily dose for the first 4 days of therapy is 50 mg (Day 1), 100 mg (Day 2), 200 mg (Day 3) and 300 mg (Day 4).

From day 4 onwards, the dose should be titrated to the usual effective dose range of 300 to 450 mg/day. Depending on the clinical response and tolerability of the individual patient, the dose may be adjusted within the range 150 to 750 mg/day.

For the treatment of moderate to se

1. Name Of The Medicinal Product

Quetiapine 200 mg Film-coated Tablets

2. Qualitative And Quantitative Composition

Each film-coated tablet contains 200 mg (as quetiapine hemifumarate).

Excipient (s):

Each 200 mg film-coated tablet contains 106.400 mg lactose monohydrate.

For a full list of excipients, see section 6.1

3. Pharmaceutical Form

Film-coated tablet

200mg tablets are white to off white, round, biconvex, film-coated tablet, plain on both sides.

4. Clinical Particulars

4.1 Therapeutic Indications

Quetiapine tablet is indicated for the treatment of:

• Schizophrenia.

• Bipolar disorder, including:

 

• moderate to severe manic episodes in bipolar disorder

 

• major depressive episodes in bipolar disorder

 

• prevention of recurrence in patients whose manic or depressive episode has responded to quetiapine treatment.

4.2 Posology And Method Of Administration

Quetiapine tablets can be administered, with or without food.

Adults

For the treatment of schizophrenia: Quetiapine t

1. Name Of The Medicinal Product

Quinoderm 10% / 0.5% w/w Cream

2. Qualitative And Quantitative Composition

Benzoyl Peroxide, hydrous

10.0% w/w

Potassium Hydroxyquinoline Sulphate

0.5% w/w

Excipients: Also includes cetostearyl alcohol, approx 0.825% w/w

For full list of excipients, see section 6.1

3. Pharmaceutical Form

Quinoderm Cream is a creamy white astringent vanishing cream. It is intended for topical use only.

4. Clinical Particulars

4.1 Therapeutic Indications

Acne vulgaris, acneform eruptions, folliculitis.

4.2 Posology And Method Of Administration

Route of administration

For topical use only.

Adults, children and the elderly

By gentle massage over all the affected area two or three times daily.

4.3 Contraindications

Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream.

4.4 Special Warnings And Precautions For Use

Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.

In a few isolated cases, overreaction to Quinoderm Cream may occur. To minimise this possibility

1. Name Of The Medicinal Product

QUINODERM™ LOTIO-GEL 5%

2. Qualitative And Quantitative Composition

Benzoyl Peroxide BP

5.0%

Potassium Hydroxyquinoline Sulphate BP

0.5%

3. Pharmaceutical Form

Quinoderm Lotio-gel 5% is a homogeneous astringent gel formulated to give the colour and consistency of a creamy white lotion. It is intended for topical use only.

4. Clinical Particulars

4.1 Therapeutic Indications

Acne

4.2 Posology And Method Of Administration

Route of administration: For topical use only.

Adults, children and the elderly

By gentle massage over all the affected area one to three times daily.

4.3 Contraindications

Patients with known sensitivity to either of the active constituents should not use Quinoderm Lotio-gel 5%.

4.4 Special Warnings And Precautions For Use

Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.

In a few isolated cases, overreaction to Quinoderm Lotio-gel 5% may occur. To minimise this possibility, select a small area of skin behind the ear, apply the cream and leave for twelve hours. If severe irritation or pronounced redness occurs, do not proceed with treatment.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

Benzoyl peroxide is an oxidi

1. Name Of The Medicinal Product

Qvar 50 Aerosol 50 micrograms per actuation pressurised inhalation solution

2. Qualitative And Quantitative Composition

Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.

(The dose delivered from the mouthpiece is an average 37.5 micrograms).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Pressurised inhalation, solution.

A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.

Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).

4. Clinical Particulars

4.1 Therapeutic Indications

Prophylactic management of mild, moderate or severe asthma.

4.2 Posology And Method Of Administration

Qvar is for inhalation use only.

Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.

NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.

ADULT STARTING AND MAINTENANCE DOSE:

It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.

To be effective, inhaled Qvar must be used on a regular basis even when patients are asymptomatic.

TH

1. Name Of The Medicinal Product

Questran Powder for Oral Suspension 4g

2. Qualitative And Quantitative Composition

Each sachet contains 4g anhydrous colestyramine (a basic anion-exchange resin).

3. Pharmaceutical Form

Powder for Oral Suspension.

4. Clinical Particulars

4.1 Therapeutic Indications

Questran is used for:

1.

Primary prevention of coronary heart disease in men between 35 and 59 years of age and with primary hypercholesterolaemia who have not responded to diet and other appropriate measures.

2.

Reduction of plasma cholesterol in hypercholesterolaemia, particularly in those patients who have been diagnosed as Fredrickson's Type II (high plasma cholesterol with normal or slightly elevated triglycerides).

3.

Relief of pruritus associated with partial biliary obstruction and primary biliary cirrhosis.

4.

Relief of diarrhoea associated with ileal resection, Crohn's disease, vagotomy and diabetic vagal neuropathy.

Quinine Sulphate 200mg tablets

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

Index

1 What Quinine sulphate tablets are and what they are used for
2 Before you take
3 How to take
4 Possible side effects
5 How to store
6 Further information

What Quinine sulphate tablets are and what they are used for

Quinine sulphate belongs to a group of medicines called anti-protozoal agents and they are used to treat:

  • malaria
  • and prevent night cramps in adults and the elderly when sleep is regularly disrupted

Before you take

Do not take Quinine sulphate tablets and tell your doctor if you have:

  • an allergy (hypersensitivity) to quinine (including that in tonic waters or other beverages), quinoline or any of the other ingredients (see section 6)
  • blood in your urine
  • ringing in your ears
  • suffer from muscle weakness (myasthenia gravis)
  • problems with your eyes or difficulty seeing

Check with your doctor or pharmacist before taking Quinine sulphate tablets i

1. Name Of The Medicinal Product

QUINODERM CREAM 5

2. Qualitative And Quantitative Composition

Benzoyl Peroxide BP 5.0%

Potassium Hydroxyquinoline Sulphate BP 0.5%

3. Pharmaceutical Form

Quinoderm Cream 5 is a creamy white astringent vanishing cream.

It is intended for topical use only.

4. Clinical Particulars

4.1 Therapeutic Indications

Acne vulgaris, acneform eruptions, folliculitis.

4.2 Posology And Method Of Administration

Route of administration

For topical use only.

Adults, children and the elderly:

By gentle massage over all the affected area two or three times daily.

4.3 Contraindications

Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream 5.

4.4 Special Warnings And Precautions For Use

Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely dye fastness.

In a few isolated cases, overreaction to Quinoderm Cream 5 may occur. To minimise this possibility, select a small area of skin behind the ear, apply the cream and leave for twelve hours. If severe irritation or pronounced redness occurs, do not proceed with treatment.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

Benzoyl Peroxide is an oxidising agent. Hence, Quinoderm Cream 5 should not be used at the same time as other topical agents which would react with an oxidising agent.

4.6 Pregnancy And Lactation

Quinoderm Cream 5 is not contra-indicated in pregnancy or lactation.

1. Name Of The Medicinal Product

Qvar 100 Autohaler 100 micrograms per actuation pressurised inhalation solution.

2. Qualitative And Quantitative Composition

Beclometasone Dipropionate 100 micrograms per metered (ex-valve) dose.

(The dose delivered from the mouthpiece is an average 75 micrograms).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Pressurised inhalation, solution.

A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.

Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).

4. Clinical Particulars

4.1 Therapeutic Indications

Prophylactic management of mild, moderate or severe asthma.

4.2 Posology And Method Of Administration

Qvar is for oral inhalation use only

Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.

NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.

ADULT STARTING AND MAINTENANCE DOSE:

It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.

To be effective, inhaled Qvar must be used on a regular basis even when patients are asymptomatic.

1. Name Of The Medicinal Product

Quinapril/Hydrochlorothiazide 20/12.5 mg film-coated tablets

2. Qualitative And Quantitative Composition

20 /12.5 mg:

Each film-coated tablet contains 20 mg of quinapril equivalent to 21.66 mg of quinapril hydrochloride and 12.5 mg hydrochlorothiazide.

Excipient: Each film-coated tablet contains 35.56 mg of lactose (as lactose monohydrate).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Film-coated tablet.

20mg/12.5mg:

Pink coloured, triangular, biconvex, film-coated tablets debossed with 'D' and '19' on either sides of a scoreline on one side and plain on the other side.

The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

4. Clinical Particulars

4.1 Therapeutic Indications

Quinapril/Hydrochlorothiazide is indicated as substitution therapy only in adult patients with essential hypertension already adequately controlled with quinapril and hydrochlorothiazide given concurrently.

4.2 Posology And Method Of Administration

Posology

Patients receiving quinapril and hydrochlorothiazide from separate tablets may be switched to a combination tablets of Quinapril/Hydrochlorothiazide containing the same component doses.

Adults:

The recommended dose of Quinapril/Hydrochlorothiazide is one tablet per day.

Renal impairment

Due to hydrochlorothiazide component, Quinapril/Hydrochlorothiazide is contraindicated in patients with severe renal impairment (creatinine clea

1. Name Of The Medicinal Product

Quinoderm 10% / 0.5% w/w Cream

2. Qualitative And Quantitative Composition

Benzoyl Peroxide, hydrous

10.0% w/w

Potassium Hydroxyquinoline Sulphate

0.5% w/w

Excipients: Also includes cetostearyl alcohol, approx 0.825% w/w

For full list of excipients, see section 6.1

3. Pharmaceutical Form

Quinoderm Cream is a creamy white astringent vanishing cream. It is intended for topical use only.

4. Clinical Particulars

4.1 Therapeutic Indications

Acne vulgaris, acneform eruptions, folliculitis.

4.2 Posology And Method Of Administration

Route of administration

For topical use only.

Adults, children and the elderly

By gentle massage over all the affected area two or three times daily.

4.3 Contraindications

Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream.

4.4 Special Warnings And Precautions For Use

Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.

In a few isolated cases, overreaction to Quinoderm Cream may occur. To minimise this possibility